STOCKHOLM, Sweden--(BUSINESS WIRE)--Regulatory News: Elekta (STO:EKTAB) has won seven out of ten tenders being part of the new Russian National Oncology Program. The program was initiated under the auspices of Prime Minister Vladimir Putin in early 2009 with the aim to improve prevention and early detection of cancer.
